(Q34524244)

2 August 2017

1 reference

title

Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

author name string

Kazuo Nakamura

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

publication date

1 January 2002

1 reference

CNS Neuroscience & Therapeutics

2 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

page(s)

70-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

Treatment of attention-deficit-hyperactivity disorder

12 May 2020

cites work

1 reference

12 December 2020

l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats.

1 reference

12 December 2020

Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.

1 reference

12 December 2020

The effect of aniracetam on cerebral glucose metabolism in rats after lesioning of the basal forebrain measured by PET.

1 reference

12 December 2020

Ionotropic glutamate receptor modulation of 5-HT6 and 5-HT7 mRNA expression in rat brain.

1 reference

12 December 2020

Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam.

1 reference

12 December 2020

Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).

1 reference

12 December 2020

Pharmacotherapy of attention deficit hyperactivity disorder

1 reference

12 December 2020

Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP

1 reference

12 December 2020

Pharmacokinetics of aniracetam and its metabolites in rat brain

1 reference

12 December 2020

Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats.

1 reference

12 December 2020

Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.

1 reference

12 December 2020

Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission

1 reference

12 December 2020

Effects of aniracetam on bladder overactivity in rats with cerebral infarction.

1 reference

12 December 2020

Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.

1 reference

12 December 2020

Recovery of diminished mealtime-associated anticipatory behavior by aniracetam in aged rats

1 reference

12 December 2020

Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus.

1 reference

12 December 2020

Effects of aniracetam on impaired sleep patterns in stroke-prone spontaneously hypertensive rats.

1 reference

12 December 2020

Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons

1 reference

12 December 2020

Autonomic consequences of brainstem infarction

1 reference

12 December 2020

Aniracetam restores motivation reduced by satiation in a choice reaction task in aged rats

1 reference

12 December 2020

Efficacy of acetylcholinesterase inhibitors versus nootropics in Alzheimer's disease: a retrospective, longitudinal study

1 reference

12 December 2020

Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats

1 reference

12 December 2020

Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes

1 reference

12 December 2020

Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism

1 reference

12 December 2020

Aniracetam enhances cortical dopamine and serotonin release via cholinergic and glutamatergic mechanisms in SHRSP.

1 reference

12 December 2020

Antidepressant-like effects of aniracetam in aged rats and its mode of action

1 reference

12 December 2020

Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Cholinergic and dopaminergic mechanisms involved in the recovery of circadian anticipation by aniracetam in aged rats

1 reference

12 December 2020

Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

1 reference

12 December 2020

The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

1 reference

12 December 2020

Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure.

1 reference

12 December 2020

Mesocorticolimbic dopaminergic network: functional and regulatory roles

1 reference

12 December 2020

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1 reference

12 December 2020

Aniracetam improves behavioural responses and facilitates signal transduction in the rat brain.

1 reference

12 December 2020

Effects of aging on food-entrained circadian rhythms in the rat.

1 reference

12 December 2020

The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.

1 reference

12 December 2020

Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease

1 reference

12 December 2020

Excitatory and inhibitory influences on bladder activity elicited by electrical stimulation in the pontine micturition center in the rat

1 reference

12 December 2020

The dopamine and serotonin systems during aging in human and rodent brain. A brief review

1 reference

12 December 2020

The use of a plus-maze to measure anxiety in the mouse

1 reference

12 December 2020

Cholinergic mechanisms in depression

1 reference

12 December 2020

The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs

1 reference

12 December 2020

Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.

1 reference

12 December 2020

[3H]aniracetam binds to specific recognition sites in brain membranes

1 reference

12 December 2020

Neurobiology of impulsivity and the impulse control disorders

1 reference

12 December 2020

Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

1 reference

12 December 2020

1 reference

12 December 2020

Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task.

1 reference

12 December 2020

Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells

1 reference

12 December 2020

Piracetam and other structurally related nootropics

1 reference

12 December 2020

Dopamine and depression

1 reference

12 December 2020

Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells.

1 reference

12 December 2020

Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo.

1 reference

12 December 2020

Amelioration by aniracetam of abnormalities as revealed in choice reaction performance and shuttle behavior.

1 reference

12 December 2020

Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders

1 reference

12 December 2020

Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult rats.

1 reference

12 December 2020

DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex

1 reference

12 December 2020

Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice

1 reference

12 December 2020

Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes.

1 reference

12 December 2020

Neurite outgrowth of murine cerebellar granule cells can be enhanced by aniracetam with or without alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)

1 reference

12 December 2020

Psychopharmacology of central serotonergic systems

1 reference

12 December 2020

Serotonin receptors and their function in sleep, anxiety disorders and depression

1 reference

12 December 2020

Role of 5-HT in stress, anxiety, and depression.

1 reference

12 December 2020

Activation of Multiple Metabotropic Glutamate Receptor Subtypes Prevents NMDA-induced Excitotoxicity in Rat Hippocampal Slices

1 reference

12 December 2020

Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing.

1 reference

12 December 2020

Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries

1 reference

12 December 2020

NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role.

1 reference

12 December 2020

Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats.

1 reference

12 December 2020

Arousal systems and attentional processes.

1 reference

12 December 2020

Aniracetam for treatment of patients with progressive supranuclear palsy

1 reference

12 December 2020

Enhancement of contextual fear-conditioning by putative (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA/2J mice.

1 reference

12 December 2020

Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms.

1 reference

12 December 2020

Cognitive impairment in spontaneously hypertensive rats: role of central nicotinic receptors. I.

1 reference

12 December 2020

Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats.

1 reference

12 December 2020

N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.

1 reference

12 December 2020

Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam.

1 reference

12 December 2020

Pharmacokinetics of aniracetam and its metabolites in rats

1 reference

12 December 2020

Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease.

1 reference

12 December 2020

Anatomy of the central neural pathways controlling the lower urinary tract.

1 reference

12 December 2020

Presynaptic modulation of synaptic transmission and plasticity by brain-derived neurotrophic factor in the developing hippocampus.

1 reference

12 December 2020

Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test

1 reference

12 December 2020

Problems in the management of attention-deficit-hyperactivity disorder.

1 reference

12 December 2020

10.1111/J.1527-3458.2002.TB00216.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741661&resulttype=core&format=json

12 May 2020

1 reference